Back

Early aortic valve replacement in asymptomatic severe aortic stenosis: a systematic review and meta-analysis of randomized controlled trials

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Multi-valve disease Treatment ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Juliana Giorgi

Sao Paulo (Brazil)

7 More presentations in this session

Presentation thumbnail
Aorto-mitral angle as a geometric predictor of prosthetic mitral valve deterioration: insights from a retrospective case-control study
Doctor N. Changklungkul (Bangkok, TH)
Abstract Slides Video
Presentation thumbnail
Aortic valve replacement in asymptomatic individuals with severe aortic stenosis and left ventricular hypertrophy
Associate Professor J. Wasfy (Boston, US)
Abstract Slides Video
Presentation thumbnail
Comparison of outcomes between TAVI and SAVR in patients with bicuspid aortic valve stenosis
Doctor K. Faierstein (Ramat Gan, IL)
Abstract Slides Video
Presentation thumbnail
Sex-based differences in incidence and mortality of repeat mitral valve surgery for mitral regurgitation: a nationwide cohort study
Miss A. Koeber (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Development of a risk score for predicting 30-day mortality in Brazilian heart valve surgery patients
Doctor D. Cian Nazzetta (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Multi-valve disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Comparative analysis of early stroke risk in transcatheter versus surgical aortic valve replacement in elderly patients: a systematic review and meta-analysis
thumbnail
Congress Presentation
Aortic valve replacement in asymptomatic individuals with severe aortic stenosis and left ventricular hypertrophy
thumbnail
Congress Presentation
Current trends in aortic stenosis presentation, progression and treatment a retrospective cohort study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources